AlphaStreet Newsdesk powered by AlphaStreet Intelligence
Lantheus Holdings, Inc. (LNTH) posted Q3 2026 adjusted fully diluted earnings per share EPS of $1.68. Revenue totaled $389.9M for the quarter. The top-line was up 1.5% year-over-year.
Lantheus is a drug manufacturer. PYLARIFY sales were $239M for the quarter, down 0.7% year-over-year. The company recorded $684 million of cash and cash equivalents in Q3. The company earned $22.4M in net income.
Wall Street consensus stands at 10 buy, 4 hold, 0 sell.
A detailed analysis of Lantheus Holdings, Inc.’s quarter follows shortly on AlphaStreet.
This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.